Personal Genome Diagnostics Inc:医療機器:M&Aディール及び事業提携情報

GlobalDataが発行した調査報告書(DATA904C10486)
◆英語タイトル:Personal Genome Diagnostics Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10486
◆発行会社(リサーチ会社):GlobalData
◆発行日:2018年11月
◆ページ数:38
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥26,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥52,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥78,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary
Personal Genome Diagnostics Inc (PGD) is a genomic solution provider. The company develops next-generation sequencing and proprietary algorithms to identify alterations in complex cancer genomes. It provides a portfolio of regulated tissue-based and liquid biopsy genomic products for laboratories. PGD offers high-throughput next-generation sequencing and proprietary algorithms to identify alterations in complex cancer genomes. It provides custom solutions such as cancer whole genome analysis, cancer genome germline analysis, sample preparation and sequencing, data interpretation and analysis, cancer bioinformatic analysis and ctDNA analyses, among others. The company caters to academics, biotechnology and pharmaceutical companies, and contract research organizations. PGD is headquartered in Baltimore, Maryland, the US.

Personal Genome Diagnostics Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Personal Genome Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Personal Genome Diagnostics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Personal Genome Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Personal Genome Diagnostics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Personal Genome Diagnostics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Personal Genome Diagnostics Inc, Medical Equipment, Deal Details 11
Venture Financing 11
Personal Genome Diagnostics Raises USD75 Million in Series B Financing 11
Personal Genome Diagnostics Raises USD65.4 Million in Venture Financing 13
Personal Genome Diagnostics Raises USD4.3 Million in Venture Financing 14
Personal Genome Diagnostics Raises US$2.8 Million In Venture Financing 15
Personal Genome Diagnostics Raises US$2 Million In Venture Financing 16
Private Equity 17
Innovatus Capital Partners to Invest up to USD42 Million in Personal Genome Diagnostics 17
Partnerships 18
Personal Genome Diagnostics Enters into Licensing Agreement with Memorial Sloan Kettering Cancer 18
Personal Genome Diagnostics Enters into Licensing Agreement with Johns Hopkins University 19
Personal Genome Diagnostics Enters into Licensing Agreement with Human Longevity 20
QIAGEN Enters Into Licensing Agreement With Personal Genome Diagnostics 21
Personal Genome Diagnostics Enters into Agreement Five Prime Therapeutics 22
Personal Genome Diagnostics Enters into Co-Development Agreement with Illumina 23
Cure Forward Enters into Agreement with Personal Genome Diagnostics 24
Personal Genome Diagnostics And MolecularMD Enter Into Agreement For Genomic Testing Services 25
Personal Genome Diagnostics Enters Into Co-Development Agreement With Blueprint Medicines For Novel Kinase Targets 26
Personal Genome Enters Into Licensing Agreement With Johns Hopkins University 27
Personal Genome Diagnostics Inc – Key Competitors 28
Personal Genome Diagnostics Inc – Key Employees 29
Personal Genome Diagnostics Inc – Locations And Subsidiaries 30
Head Office 30
Recent Developments 31
Corporate Communications 31
Jan 17, 2017: Personal Genome Diagnostics Adds James Lewis as Senior Vice President of Corporate Development 31
Product News 32
Dec 14, 2017: Liquid Biopsy Results Differed Substantially Between Two Providers 32
Jun 02, 2017: Personal Genome Diagnostics Highlights its Patent-Pending Microsatellite Instability Testing Technology as FDA Approves Keytruda for MSI Tumors 33
Mar 30, 2017: Personal Genome Diagnostics Announces AACR Annual Meeting 2017 Presentations and Awards 34
Jan 04, 2017: Personal Genome Diagnostics ImmunoSELECT Technology Demonstrates How Resistance to Checkpoint Blockade Therapy Evolves in Cancer Discovery Study 35
Other Significant Developments 36
Sep 05, 2018: Machine learning approach by Personal Genome Diagnostics outperforms existing mutation detection methods according to study in Science Translational Medicine 36
Nov 10, 2017: U.S. Dept. of Veterans Affairs Renews and Expands Cancer Testing Contract with Personal Genome Diagnostics 37
Appendix 38
Methodology 38
About GlobalData 38
Contact Us 38
Disclaimer 38

List of Tables
Personal Genome Diagnostics Inc, Medical Equipment, Key Facts 2
Personal Genome Diagnostics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Personal Genome Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Personal Genome Diagnostics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Personal Genome Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Personal Genome Diagnostics Inc, Deals By Market, 2012 to YTD 2018 8
Personal Genome Diagnostics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Personal Genome Diagnostics Raises USD75 Million in Series B Financing 11
Personal Genome Diagnostics Raises USD65.4 Million in Venture Financing 13
Personal Genome Diagnostics Raises USD4.3 Million in Venture Financing 14
Personal Genome Diagnostics Raises US$2.8 Million In Venture Financing 15
Personal Genome Diagnostics Raises US$2 Million In Venture Financing 16
Innovatus Capital Partners to Invest up to USD42 Million in Personal Genome Diagnostics 17
Personal Genome Diagnostics Enters into Licensing Agreement with Memorial Sloan Kettering Cancer 18
Personal Genome Diagnostics Enters into Licensing Agreement with Johns Hopkins University 19
Personal Genome Diagnostics Enters into Licensing Agreement with Human Longevity 20
QIAGEN Enters Into Licensing Agreement With Personal Genome Diagnostics 21
Personal Genome Diagnostics Enters into Agreement Five Prime Therapeutics 22
Personal Genome Diagnostics Enters into Co-Development Agreement with Illumina 23
Cure Forward Enters into Agreement with Personal Genome Diagnostics 24
Personal Genome Diagnostics And MolecularMD Enter Into Agreement For Genomic Testing Services 25
Personal Genome Diagnostics Enters Into Co-Development Agreement With Blueprint Medicines For Novel Kinase Targets 26
Personal Genome Enters Into Licensing Agreement With Johns Hopkins University 27
Personal Genome Diagnostics Inc, Key Competitors 28
Personal Genome Diagnostics Inc, Key Employees 29

List of Figures
Personal Genome Diagnostics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Personal Genome Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Personal Genome Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Personal Genome Diagnostics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Personal Genome Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Personal Genome Diagnostics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Personal Genome Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Personal Genome Diagnostics Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Personal Genome Diagnostics Inc:医療機器:M&Aディール及び事業提携情報(Personal Genome Diagnostics Inc - Medical Equipment - Deals and Alliances Profile)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆